IMAGEWARE SYSTEMS INC

2022 Q2 Form 10-Q Financial Statement

#000185173422000293 Filed on May 23, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $832.0K $1.202M
YoY Change -83.54% -85.6%
Cash & Equivalents $832.0K $1.202M
Short-Term Investments
Other Short-Term Assets $110.0K $215.0K
YoY Change -82.4% 9.69%
Inventory $24.00K $25.00K
Prepaid Expenses
Receivables $314.0K $383.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.280M $1.825M
YoY Change -79.56% -80.07%
LONG-TERM ASSETS
Property, Plant & Equipment $74.00K $79.00K
YoY Change -95.3% -49.03%
Goodwill $3.416M $3.416M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $149.0K $149.0K
YoY Change -71.62% -67.47%
Total Long-Term Assets $4.447M $4.491M
YoY Change -20.16% -20.43%
TOTAL ASSETS
Total Short-Term Assets $1.280M $1.825M
Total Long-Term Assets $4.447M $4.491M
Total Assets $5.727M $6.316M
YoY Change -51.6% -57.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $937.0K $837.0K
YoY Change -3.8% -16.88%
Accrued Expenses $1.555M $1.518M
YoY Change 7.91% 34.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.603M $524.0K
YoY Change 44.81% -42.92%
Total Short-Term Liabilities $11.57M $9.871M
YoY Change -57.39% -65.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $2.641M $0.00
YoY Change -29.78% -100.0%
Total Long-Term Liabilities $2.641M $0.00
YoY Change -37.49% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.57M $9.871M
Total Long-Term Liabilities $2.641M $0.00
Total Liabilities $14.21M $12.65M
YoY Change -54.71% -61.73%
SHAREHOLDERS EQUITY
Retained Earnings -$207.0M -$204.3M
YoY Change -4.21%
Common Stock $3.471M $3.471M
YoY Change 92.73%
Preferred Stock
YoY Change
Treasury Stock (at cost) $64.00K $64.00K
YoY Change 0.0%
Treasury Stock Shares $6.704K $6.704K
Shareholders Equity -$18.96M -$15.09M
YoY Change
Total Liabilities & Shareholders Equity $5.727M $6.316M
YoY Change -51.6% -57.33%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
347962742
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
25000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
25000 USD
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
347281946
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
347240045
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347275242
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347233341
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
6704
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
6704
CY2022Q1 iwsy Capitalized Contract Cost Additions
CapitalizedContractCostAdditions
0 USD
CY2022Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 pure
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
154000 USD
CY2022Q1 iwsy Warrants Or Rights Cancelled During Period
WarrantsOrRightsCancelledDuringPeriod
0
CY2022Q1 iwsy Warrants Or Rights Exercised During Period
WarrantsOrRightsExercisedDuringPeriod
0
CY2022Q1 iwsy Warrants Or Rights Expired During Period
WarrantsOrRightsExpiredDuringPeriod
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
832000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1202000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
314000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
383000 USD
CY2022Q1 us-gaap Inventory Net
InventoryNet
24000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
25000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
110000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
1280000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1825000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
79000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
149000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
149000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
808000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
847000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
3416000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
3416000 USD
CY2022Q1 us-gaap Assets
Assets
5727000 USD
CY2021Q4 us-gaap Assets
Assets
6316000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
937000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
837000 USD
CY2022Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
955000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1204000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1555000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1518000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
495000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
496000 USD
CY2022Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6024000 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5292000 USD
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
1603000 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
215000 USD
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
524000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11569000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9871000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
686000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
802000 USD
CY2022Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
1955000 USD
CY2021Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
1976000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
14210000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
12649000 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
3471000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3471000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
185956000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
187148000 USD
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
64000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
64000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1375000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1396000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-206951000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-204253000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-18961000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-15092000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5727000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6316000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
845000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
733000 USD
CY2022Q1 us-gaap Gross Profit
GrossProfit
713000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
614000 USD
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1176000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1347000 USD
CY2022Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
626000 USD
CY2021Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
724000 USD
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
868000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1168000 USD
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6000 USD
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18000 USD
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
2676000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
3257000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1963000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2643000 USD
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-53000 USD
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-0 USD
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-667000 USD
CY2021Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1172000 USD
CY2022Q1 iwsy Gains Losses On Extinguishment Of Derivative Liabilities And Debt
GainsLossesOnExtinguishmentOfDerivativeLiabilitiesAndDebt
0 USD
CY2021Q1 iwsy Gains Losses On Extinguishment Of Derivative Liabilities And Debt
GainsLossesOnExtinguishmentOfDerivativeLiabilitiesAndDebt
335000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000 USD
CY2022Q1 us-gaap Pension Expense
PensionExpense
20000 USD
CY2021Q1 us-gaap Pension Expense
PensionExpense
54000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2698000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1885000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2698000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1885000 USD
CY2022Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
1797000 USD
CY2021Q1 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2255000 USD
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4495000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4140000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
347257550
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
245829914
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2698000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1885000 USD
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
21000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
54000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2677000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1831000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-15092000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
1531000 USD
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
592000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
21000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2698000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-18961000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-19823000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
1817000 USD
CY2021Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
78000 USD
CY2021Q1 iwsy Stock Issued During Period Value In Lieu Of Cash
StockIssuedDuringPeriodValueInLieuOfCash
21000 USD
CY2021Q1 iwsy Stock Issued During Period Value Warrants Exercised Amount
StockIssuedDuringPeriodValueWarrantsExercisedAmount
0 USD
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
687000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
54000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1885000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-22933000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2698000 USD
CY2021Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1885000 USD
CY2022Q1 us-gaap Depreciation
Depreciation
6000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
18000 USD
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
29000 USD
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-0 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-82000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
592000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
78000 USD
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
CY2021Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
21000 USD
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-335000 USD
CY2022Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-667000 USD
CY2021Q1 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1172000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-69000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-84000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
48000 USD
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-104000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
495000 USD
CY2022Q1 iwsy Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
78000 USD
CY2021Q1 iwsy Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
10000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
100000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-33000 USD
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-249000 USD
CY2021Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-129000 USD
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
37000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-123000 USD
CY2022Q1 us-gaap Increase Decrease In Pension Plan Obligations
IncreaseDecreaseInPensionPlanObligations
-21000 USD
CY2021Q1 us-gaap Increase Decrease In Pension Plan Obligations
IncreaseDecreaseInPensionPlanObligations
-13000 USD
CY2022Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1257000 USD
CY2021Q1 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-1405000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1441000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3290000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53000 USD
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1050000 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1050000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
21000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-370000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3289000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1202000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8345000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
832000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5056000 USD
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
0 USD
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q1 iwsy Working Capital Deficit
WorkingCapitalDeficit
-10289000 USD
CY2021Q4 iwsy Working Capital Deficit
WorkingCapitalDeficit
-8046000 USD
CY2022Q1 us-gaap Derivative Liabilities
DerivativeLiabilities
6024000 USD
CY2022Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
23469000 USD
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;"><i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expense during the reporting period. Significant estimates include the evaluation of our ability to continue as a going concern, the allowance for doubtful accounts receivable, assumptions used in the Black-Scholes model to calculate the fair value of share based payments, fair value of financial instruments issued with and affected by the Series D Financing, assumptions used in the application of revenue recognition policies, and assumptions used in the application of fair value methodologies to calculate the fair value of pension assets and obligations. Actual results could differ from estimates.</p>
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1797000 USD
CY2021Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2255000 USD
CY2022Q1 iwsy Net Income Loss Available To Common Shareholders
NetIncomeLossAvailableToCommonShareholders
-4495000 USD
CY2021Q1 iwsy Net Income Loss Available To Common Shareholders
NetIncomeLossAvailableToCommonShareholders
-4140000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
347275242
CY2021Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
245829914
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.145 pure
CY2022Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 USD
CY2022Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
0 USD
CY2022Q1 us-gaap Revenues
Revenues
845000 USD
CY2021Q1 us-gaap Revenues
Revenues
733000 USD
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18000 USD
CY2022Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/><p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Customer Concentration</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:34pt;">For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2022, </em><em style="font: inherit;">two</em> customers accounted for approximately 37% or $314,000 of our total revenue and had trade receivables at <em style="font: inherit;"> March 31, 2022 </em>of $35,000.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2021, </em><em style="font: inherit;">two</em> customers accounted for approximately 45% or $333,000 of our total revenue and had trade receivables of $249,000 at <em style="font: inherit;"> March 31, 2021.</em></p>
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2698000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1885000 USD
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
491597864
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
454334941
CY2022Q1 us-gaap Inventory Gross
InventoryGross
24000 USD
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
7000 USD
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17000 USD
CY2022Q1 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
3000 USD
CY2021Q4 us-gaap Inventory Gross
InventoryGross
25000 USD
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
7000 USD
CY2021Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
3000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.145 pure
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
808000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1181000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
847000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
1298000 USD
CY2022Q1 us-gaap Lease Cost
LeaseCost
154000 USD
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y3M29D
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
162000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
166000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
490000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
424000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
387000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
132000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1433000 USD
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
252000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1181000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
495000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
686000 USD
CY2020Q2 iwsy Common And Preferred Stock Shares Authorized
CommonAndPreferredStockSharesAuthorized
179000000
CY2020Q2 iwsy Common And Preferred Stock Shares Authorized
CommonAndPreferredStockSharesAuthorized
350000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
345000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000.0
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000.0
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000.0
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
347281946
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347275242
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
347240045
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347233341
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347233341
CY2022Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
41901
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
347275242
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
3150000
CY2022Q1 iwsy Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
1466680
CY2022Q1 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 USD
CY2022Q1 iwsy Warrants Or Rights Issued During Period
WarrantsOrRightsIssuedDuringPeriod
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4818876
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y6M
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-0
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4818876
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.08
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
P3Y2M12D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4818876
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3633444
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.08
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y2M12D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3633444
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1185432
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4818876
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4818876
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.08
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
592000 USD
CY2021Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
78000 USD
CY2022Q1 us-gaap Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets
DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
1643000 USD
CY2022Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1643000 USD
CY2022Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6024000 USD
CY2022Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
6024000 USD
CY2021Q4 us-gaap Defined Benefit Plan Pension Plans With Accumulated Benefit Obligations In Excess Of Plan Assets Aggregate Fair Value Of Plan Assets
DefinedBenefitPlanPensionPlansWithAccumulatedBenefitObligationsInExcessOfPlanAssetsAggregateFairValueOfPlanAssets
1689000 USD
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1689000 USD
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5292000 USD
CY2021Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
5292000 USD

Files In Submission

Name View Source Status
0001851734-22-000293-index-headers.html Edgar Link pending
0001851734-22-000293-index.html Edgar Link pending
0001851734-22-000293.txt Edgar Link pending
0001851734-22-000293-xbrl.zip Edgar Link pending
ex_376701.htm Edgar Link pending
ex_376702.htm Edgar Link pending
ex_376703.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
iwsy-20220331.xsd Edgar Link pending
iwsy-20220331_cal.xml Edgar Link unprocessable
iwsy-20220331_def.xml Edgar Link unprocessable
iwsy-20220331_lab.xml Edgar Link unprocessable
iwsy-20220331_pre.xml Edgar Link unprocessable
iwsy20220331_10q.htm Edgar Link pending
iwsy20220331_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending